Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Compounded "semaglutide" is not FDA approved semaglutide.com FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News Triangle Compounding Pharmacy Inc, Cary, NC. 483 Issued 07 13 2017 FDA's Overreach on Compounded Peptides